We are live on ! Find out more
IPXL

Impax Laboratories, Inc.
IPXL

Delisted

IPXL was delisted on the 4th of May, 2018.

Back to rankings

178 hedge funds and large institutions have $792M invested in Impax Laboratories, Inc. in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 75 increasing their positions, 47 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 47

43% more call options, than puts

Call options by funds: $2.75M | Put options by funds: $1.93M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less capital invested

Capital invested by funds: $795M → $792M (-$3.15M)

10% less funds holding

Funds holding: 198 → 178 (-20)

30% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 44

Holders
178
Holders Change
-20
Holders Change %
-10.1%
% of All Funds
4.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
75
Reduced
47
Closed
44
Calls
$2.75M
Puts
$1.93M
Net Calls
+$823K
Net Calls Change
+$1.46M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$131M
2
Millennium Management
Millennium Management
New York
+$26.7M
3
Citadel Advisors
Citadel Advisors
Florida
+$18.5M
4
FCM
Frontier Capital Management
Massachusetts
+$13.4M
5
SIG
Senator Investment Group
New York
+$13.3M

Top Sellers

Rank Fund Capital Flow
1
HP
Hound Partners
New York
-$58.8M
2
Franklin Resources
Franklin Resources
California
-$28.8M
3
Victory Capital Management
Victory Capital Management
Texas
-$16.9M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$15.9M
5
NIMC
NWQ Investment Management Company
California
-$13.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Massachusetts Financial Services
126
Massachusetts Financial Services
Massachusetts
$182K +$2.06K +171 +1%
TSW
127
Thompson Siegel & Walmsley
Virginia
$177K +$169K +14,000 New
DekaBank Deutsche Girozentrale
128
DekaBank Deutsche Girozentrale
Germany
$166K -$13.3K -1,100 -8%
Public Employees Retirement Association of Colorado
129
Public Employees Retirement Association of Colorado
Colorado
$162K – – –
UB
130
UMB Bank
Missouri
$147K – – –
CB
131
Commerce Bank
Missouri
$145K +$15.8K +1,310 +13%
GS
132
GAM Systematic
United Kingdom
$138K +$132K +10,912 New
Los Angeles Capital Management
133
Los Angeles Capital Management
California
$130K -$7.13K -590 -5%
PI
134
PineBridge Investments
New York
$121K +$2.77K +229 +2%
SOADOR
135
State of Alaska Department of Revenue
Alaska
$102K +$1.81K +150 +2%
PCM
136
Prelude Capital Management
New York
$83K -$838K -69,360 -91%
AIP
137
Ameritas Investment Partners
Nebraska
$80K +$76.4K +6,324 New
Ohio Public Employees Retirement System (OPERS)
138
Ohio Public Employees Retirement System (OPERS)
Ohio
$78K +$25.1K +2,079 +51%
FPF
139
FNY Partners Fund
New York
$75K +$24.2K +2,000 +50%
GHCM
140
Glen Harbor Capital Management
California
$63K +$10.3K +850 +20%
Citigroup
141
Citigroup
New York
$56K -$1.9M -157,146 -97%
MCIM
142
Meadow Creek Investment Management
Georgia
$52K +$8.46K +700 +20%
LIA
143
LS Investment Advisors
Michigan
$41K – – –
EP
144
Elkfork Partners
Oregon
$41K +$6.64K +550 +20%
MAM
145
Meeder Asset Management
Ohio
$40K +$37.7K +3,118 New
Envestnet Asset Management
146
Envestnet Asset Management
Illinois
$39K +$4.3K +356 +13%
SEI Investments
147
SEI Investments
Pennsylvania
$37K -$992K -82,148 -97%
JG
148
Jefferies Group
New York
$35K -$654K -54,160 -95%
LCM
149
Legato Capital Management
California
$30K – – –
Zurich Cantonal Bank
150
Zurich Cantonal Bank
Switzerland
$30K – – –
4 5
6
7 8

IPXL Hedge Fund Activity: Q1 2017 in Review

178 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q1 2017, worth a combined $792M — down 0.4% from $795M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IPXL and 31 opened new positions — a net loss of 13 holders — while 47 trimmed existing stakes and 75 added.

The largest buyer was BlackRock, adding an estimated $131M. The largest seller was Hound Partners, exiting entirely with an estimated $58.8M sold.

  • 178 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q1 2017, down from 198 in Q4 2016.
  • Funds reported $792M of Impax Laboratories, Inc. stock for Q1 2017, down 0.4% quarter-over-quarter.
  • 31 funds opened new Impax Laboratories, Inc. positions in Q1 2017 and 44 closed out, a net change of -13 holders.
  • The largest Impax Laboratories, Inc. buyer in Q1 2017 was BlackRock, an estimated $131M added.
  • The largest Impax Laboratories, Inc. seller in Q1 2017 was Hound Partners, an estimated $58.8M sold.

Based on aggregated 13F filings for Q1 2017.